Harry Lampiris, MD
|
Title(s) | Professor, Medicine |
---|
School | School of Medicine |
---|
Address | VAMC San Francisco CA 94121
|
---|
Phone | 415-379-5608 ext. 23613 |
---|
vCard | Download vCard |
---|
|
|
Biography University of California, San Francisco | Post-Doc Fellow/Scholar | 1991 | School of Medicine | University of California, San Francisco | Residency | | School of Medicine | University of California, San Francisco | M.D. | 1985 | School of Medicine |
Overview ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Cycle Threshold to Test Positivity in COVID-19 for Return to Work Clearance in Health Care Workers. J Occup Environ Med. 2020 11; 62(11):889-891.
Domeracki S, Clapp RN, Taylor K, Lu CM, Lampiris H, Blanc PD. PMID: 32804748.
View in: PubMed Mentions: Fields: Translation: HumansCellsPHPublic Health
-
Opportunistic coinfection with Pneumocystis jirovecii and Coccidioides immitis associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia. BMJ Case Rep. 2020 Apr 29; 13(4).
Ward LM, Peluso MJ, Budak JZ, Elicker BM, Chin-Hong PV, Lampiris H, Mulliken JS. PMID: 32354764.
View in: PubMed Mentions: Fields:
-
Response to: Is Burnout Infectious? Understanding Drivers of Burnout and Job Satisfaction Among Academic Infectious Diseases Physicians. Open Forum Infect Dis. 2020 Apr; 7(4):ofaa098.
Budak JZ, Brickman CE, Abdoler EA, Wallender EK, Mulliken JS, Kerkhoff AD, Lampiris H, Babik JM, Koss CA, Schwartz BS. PMID: 32284950.
View in: PubMed Mentions:
-
Evaluating the Concordance of Clinician Antiretroviral Prescribing Practices and HIV-ASSIST, an Online Clinical Decision Support Tool. J Gen Intern Med. 2020 May; 35(5):1498-1503.
Ramirez JA, Maddali MV, Budak JZ, Li JZ, Lampiris H, Shah M. PMID: 31792870.
View in: PubMed Mentions: Fields:
-
2534. Development of an Infectious Diseases Fellowship Well-Being Program. Open Forum Infectious Diseases. 2019 Oct 23; 6(Suppl 2):s881-s881.
Jehan Budak, Cristina Brickman, Emily Abdoler, Erika Wallender, Jennifer S Mulliken, Andrew D Kerkhoff, Harry Lampiris, Jennifer M Babik, Catherine Koss, Brian Schwartz, Brian Schwartz. .
View in: Publisher Site Mentions:
-
HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med. 2018 02 28; 10(430).
Yukl SA, Kaiser P, Kim P, Telwatte S, Joshi SK, Vu M, Lampiris H, Wong JK. PMID: 29491188.
View in: PubMed Mentions: 52 Fields: Translation: HumansCells
-
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat Med. 2016 07; 22(7):807-11.
PMID: 27294875.
View in: PubMed Mentions: 32 Fields: Translation: HumansCells
-
Neuraminidase Inhibitors and Influenza Infection-Reply. JAMA Intern Med. 2016 Mar; 176(3):416-7.
PMID: 26954054.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Treating Influenza With Neuraminidase Inhibitors: What Is the Evidence? JAMA Intern Med. 2015 Dec; 175(12):1899-900.
PMID: 26501509.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Geriatric Syndromes in Older HIV-Infected Adults. . 2015 Jun 01; 69(2):161-7.
PMID: 26009828.
View in: PubMed Mentions:
-
The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans. J Int Assoc Provid AIDS Care. 2015 May-Jun; 14(3):197-201.
PMID: 25487428.
View in: PubMed Mentions: 5 Fields: Translation: HumansCells
-
Management of human immunodeficiency virus infection in advanced age. JAMA. 2013 Apr 03; 309(13):1397-405.
PMID: 23549585.
View in: PubMed Mentions: 65 Fields: Translation: Humans
-
Su1471 Colorectal Neoplasia in HIV-Infected Individuals During Screening and Surveillance Colonoscopy. Gastrointestinal Endoscopy. 2012 Apr 1; 75(4):ab344.
Ma Somsouk, Susie W. Ng, Rachel Kornfield, Kenneth R. McQuaid, Harry Lampiris, John M. Inadomi. .
View in: Publisher Site Mentions:
-
Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor. Expert Rev Anti Infect Ther. 2012 Jan; 10(1):13-20.
PMID: 22149610.
View in: PubMed Mentions: 6 Fields: Translation: HumansCells
-
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. J Virol Methods. 2011 Aug; 175(2):261-5.
Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, Hare CB, Deeks SG, Liegler T, Pandori M, Havlir DV, Wong JK. PMID: 21536073.
View in: PubMed Mentions: 4 Fields: Translation: HumansCells
-
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis. 2011 Apr 01; 203(7):960-8.
Hatano H, Hayes TL, Dahl V, Sinclair E, Lee TH, Hoh R, Lampiris H, Hunt PW, Palmer S, McCune JM, Martin JN, Busch MP, Shacklett BL, Deeks SG. PMID: 21402547.
View in: PubMed Mentions: 93 Fields: Translation: HumansCells
-
CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV-negative and ART-suppressed HIV-positive patients: implications for HIV persistence in the gut. Journal of the International AIDS Society. 2010 Dec 1; 13(Suppl 3):o1.
S Yukl, E Sinclair, L Epling, Q Li, A Shergill, K McQuaid, L Duan, B Hare, H Lampiris, A Haase, D Havlir, J Wong. .
View in: Publisher Site Mentions:
-
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.
PMID: 21051598.
View in: PubMed Mentions: 549 Fields: Translation: HumansCells
-
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2010 Oct 23; 24(16):2451-60.
Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV. PMID: 20827162.
View in: PubMed Mentions: 132 Fields: Translation: HumansCells
-
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis. 2010 Nov 15; 202(10):1553-61.
Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, Choi AL, Girling V, Ho T, Li P, Fujimoto K, Lampiris H, Hare CB, Pandori M, Haase AT, Günthard HF, Fischer M, Shergill AK, McQuaid K, Havlir DV, Wong JK. PMID: 20939732.
View in: PubMed Mentions: 142 Fields: Translation: HumansCellsCTClinical Trials
-
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. . 2010 Aug; 54(4):389-93.
Hatano H, Lampiris H, Fransen S, Gupta S, Huang W, Hoh R, Martin JN, Lalezari J, Bangsberg D, Petropoulos C, Deeks SG. PMID: 20300008.
View in: PubMed Mentions:
-
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial. J Infect Dis. 2010 Mar 15; 201(6):814-22.
Zolopa AR, Berger DS, Lampiris H, Zhong L, Chuck SL, Enejosa JV, Kearney BP, Cheng AK. PMID: 20146631.
View in: PubMed Mentions: 43 Fields: Translation: HumansCellsCTClinical Trials
-
Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol. 2009 Jul; 15(4):324-33.
Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant RM, Chao LL, Truran D, Weiner MW. PMID: 19499454.
View in: PubMed Mentions: 72 Fields: Translation: Humans
-
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med. 2008 Oct 02; 359(14):1442-55.
Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E. PMID: 18832245.
View in: PubMed Mentions: 115 Fields: Translation: HumansCells
-
Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual. J Infect Dis. 2008 Mar 15; 197(6):932-3.
Shah T, Lampiris H, Vu M, Monto A, Tien PC. PMID: 18419352.
View in: PubMed Mentions: 2 Fields: Translation: HumansCells
-
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008 Jan 01; 197(1):126-33.
Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. PMID: 18171295.
View in: PubMed Mentions: 312 Fields: Translation: HumansCells
-
Covering all the bases: targeting HIV-1 integrase. . 2006 Dec 15; 43(5):507-8.
Wong JK, Lampiris H. PMID: 17133210.
View in: PubMed Mentions:
-
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006 Oct 01; 194(7):926-30.
Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. PMID: 16960780.
View in: PubMed Mentions: 60 Fields: Translation: HumansCellsCTClinical Trials
-
The independent effect of drug resistance on T cell activation in HIV infection. AIDS. 2006 Mar 21; 20(5):691-9.
Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, Liegler T, Bates M, Tsao G, Lampiris H, Hoh R, Martin JN. PMID: 16514299.
View in: PubMed Mentions: 12 Fields: Translation: HumansCells
-
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003 May 15; 187(10):1534-43.
Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. PMID: 12721933.
View in: PubMed Mentions: 367 Fields: Translation: HumansCells
-
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. Clin Infect Dis. 2002 Nov 15; 35(10):e111-2.
Hare CB, Vu MP, Grunfeld C, Lampiris HW. PMID: 12410494.
View in: PubMed Mentions: 16 Fields: Translation: Humans
-
Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. AIDS. 2002 Jun 14; 16(9):1257-63.
Schooley RT, Ruane P, Myers RA, Beall G, Lampiris H, Berger D, Chen SS, Miller MD, Isaacson E, Cheng AK. PMID: 12045491.
View in: PubMed Mentions: 47 Fields: Translation: HumansCellsCTClinical Trials
-
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2002 Jun 01; 34(11):1481-90.
Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. PMID: 12015695.
View in: PubMed Mentions: 92 Fields: Translation: HumansCellsCTClinical Trials
-
Streptococcus pneumoniae transmission in chronic-care facilities: description of an outbreak and review of management strategies. Infect Control Hosp Epidemiol. 1998 Nov; 19(11):851-3.
Sheppard DC, Bartlett KA, Lampiris HW. PMID: 9831942.
View in: PubMed Mentions: 3 Fields: Translation: HumansPHPublic Health
-
Streptococcus pneumoniae Transmission in Chronic-Care Facilities: Description of an Outbreak and Review of Management Strategies. Infection Control and Hospital Epidemiology. 1998 Nov 1; 19(11):851-853.
Donald C. Sheppard, Kathleen A. Bartlett, Harry W. Lampiris. .
View in: Publisher Site Mentions:
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
1998 | 1 | 2002 | 3 | 2003 | 1 | 2006 | 3 | 2008 | 3 | 2009 | 1 | 2010 | 6 | 2011 | 2 | 2012 | 2 | 2013 | 1 | 2014 | 1 | 2015 | 2 | 2016 | 2 | 2018 | 1 | 2019 | 2 | 2020 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|